
Loading, please wait...

Loading, please wait...

Rajasthan health officials recently initiated an RGHS Irregularities Probe to address widespread fraud within state-funded health services. Consequently, the department suspended eight medical personnel with immediate effect after a preliminary investigation revealed serious misconduct. This decisive action follows a major audit into the Rajasthan Government Health Scheme. Furthermore, officials discovered serious misuse of government funds, health cards, and facilities by the accused staff. The state government aims to curb these illegal activities through strict enforcement and changes in service rules.
Specifically, the suspended personnel include nursing officers and health workers from hospitals in Bharatpur, Phalodi, and Deeg. Because of these findings, authorities have already registered 19 FIRs against various stakeholders involved in the scheme. In addition, the government recovered approximately Rs 39 crore from hospitals and pharmacies found guilty of irregularities. Thus, the drive ensures that legitimate beneficiaries receive proper care without the interference of fraudulent claims. The latest investigation concluded that these eight individuals actively misused resources and state funds.
Q1: Who are the personnel suspended in the recent action?
The department suspended nursing officers and health workers from RBM Hospital Bharatpur, CHC Uchain, and several sub-health centers across Rajasthan districts like Deeg and Phalodi.
Q2: What is the total recovery amount from RGHS fraud cases?
As of February 2026, the state government has recovered approximately Rs 39 crore from hospitals, pharmacies, and other stakeholders involved in health scheme irregularities.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Rajasthan's health department suspended eight medical staff members following an investigation into serious irregularities within the state health scheme....
8 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A 25-year multi-institutional cohort reveals high recurrence rates in pediatric giant cell tumor of bone, particularly in patients with open physes and bone marrow edema on preoperative MRI. Early surveillance and careful balance between growth plate preservation and tumor clearance are essential.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today